Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

Cancer Research

Volumn 64, Issue 1, 2004, Pages 423-428

  Paruthiyil, Sreenivasan ^a,b   Parmar, Hema ^a,b   Kerekatte, Vaishali ^c   Cunha, Gerald R ^a,b   Firestone, Gary L ^c   Leitmant, Dale C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR BETA; MYC PROTEIN; PROTEIN P21; PROTEIN P27;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; DNA PRIMERS; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; G2 PHASE; HUMANS; MICE; MICE, NUDE; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 1642535535     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2446     Document Type: Article

References (54)

1. MacGregor, J. I., and Jordan, V. C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev., 50: 151-196, 1998.
2. Sommer, S., and Fuqua, S. A. Estrogen receptor and breast cancer. Semin. Cancer Biol., 11: 339-352, 2001.
3. Cummings, S. R., Duong, T., Kenyon, E., Cauley, J. A., Whitehead, M., and Krueger, K. A. Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA, 287: 216-220, 2002.
4. Rossouw, J. E., Anderson, G. L., Prentice, R. L., La Croix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., and Ockene, J. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288: 321-333, 2002.
5. Green, S., Walter, P., Greene, G., Krust, A., Goffin, C., Jensen, E., Scrace, G., Waterfield, M., and Chambon, P. Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem., 24: 77-83, 1986.
6. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA, 93: 5925-5930, 1996.
7. Katzenellenbogen, B. S., Montano, M. M., Ediger, T. R., Sun, J., Ekena, K., Lazennec, G., Martini, P. G., McInerney, E. M., Delage-Mourroux, R., Weis, K., and Katzenellenbogen, J. A. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog. Horm. Res., 55: 163-193, 2000.
8. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J. A. Mechanisms of estrogen action. Physiol. Rev., 81: 1535-1565, 2001.
9. Couse, J. F., and Korach, K. S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev, 20: 358-417, 1999.
10. Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M., Mahler, J. F., Sar, M., Korach, K. S., Gustafsson, J. A., and Smithies, O. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc. Natl. Acad. Sci. USA, 95: 15677-15682, 1998.
11. An, J., Tzagarakis-Foster, C., Scharschmidt, T. C., Lormi, N., and Leitman, D. C. Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem., 276: 17808-17814, 2001.
12. Oesterreich, S., Zhang, P., Guler, R. L., Sun, X., Curran, E. M., Welshons, W. V., Osborne, C. K., and Lee, A. V. Re-expression of estrogen receptor a in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res., 61: 5771-5777, 2001.
13. Fuqua, S. A., Wiltschke, C., Zhang, Q. X., Borg, A., Castles, C. G., Friedrichs, W. E., Hopp, T., Hilsenbeck, S., Mohsin, S., O'Connell, P., and Allred, D. C. A hypersensitive estrogen receptor-α mutation in premalignant breast lesions. Cancer Res., 60: 4026-4029, 2000.
14. Speirs, V., and Kerin, M. J. Prognostic significance of oestrogen receptor β in breast cancer. Br. J. Surg., 87: 405-409, 2000.
15. Gustafsson, J. A., and Warner, M. Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancer. J. Steroid Biochem. Mol. Biol., 74: 245-248, 2000.
16. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. Expression of estrogen receptor-β in human breast tumors. J. Clin. Endocrinol. Metab., 82: 2371-2374, 1997.
17. Fuqua, S. A., Schiff, R., Parra, I., Moore, J. T., Mohsin, S. K., Osborne, C. K., Clark, G. M., and Allred, D. C. Estrogen receptor β protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res., 63: 2434-2439, 2003.
18. Speirs, V., Parkes, A. T., Kerin, M. J., Walton, D. S., Carleton, P. J., Fox, J. N., and Atkin, S. L. Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? Cancer Res., 59: 525-528, 1999.
19. Jensen, E. V., Cheng, G., Palmieri, C., Saji, S., Makela, S., Van Noorden, S., Wahlstrom, T., Warner, M., Coombes, R. C., and Gustafsson, J. A. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc. Natl. Acad. Sci. USA, 4: 4, 2001.
20. Speirs, V., Malone, C., Walton, D. S., Kerin, M. J., and Atkin, S. L. Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients. Cancer Res., 59: 5421-5424, 1999.
21. Omoto, Y., Inoue, S., Ogawa, S., Toyama, T., Yamashita, H., Muramatsu, M., Kobayashi, S., and Iwase, H. Clinical value of the wild-type estrogen receptor β expression in breast cancer. Cancer Lett., 163: 207-212, 2001.
22. Iwao, K., Miyoshi, Y., Egawa, C., Ikeda, N., and Noguchi, S. Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers. Int. J. Cancer, 88: 733-736, 2000.
23. Roger, P., Sahla, M. E., Makela, S., Gustafsson, J. A., Baldet, P., and Rochefort, H. Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumors. Cancer Res., 61: 2537-2541, 2001.
24. Jarvinen, T. A., Pelto-Huikko, M., Holli, K., and Isola, J. Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am. J. Pathol., 156: 29-35, 2000.
25. Skliris, G. P., Carder, P. J., Lansdown, M. R., and Speirs, V. Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling? Br. J. Cancer, 84: 1095-1098, 2001.
26. Mann, S., Laucirica, R., Carlson, N., Younes, P. S., Ali, N., Younes, A., Li, Y., and Younes, M. Estrogen receptor β expression in invasive breast cancer. Hum. Pathol., 32: 113-118, 2001.
27. Parmar, H., Young, P., Emerman, J. T., Neve, R. M., Dairkee, S., and Cunha, G. R. A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblasts. Endocrinology, 143: 4886-4896, 2002.
28. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem., 273: 3838-3847, 1998.
29. Jiang, S. Y., and Jordan, V. C. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst., 84: 580-591, 1992.
30. Foster, J. S., Henley, D. C., Ahamed, S., and Wimalasena, J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab., 12: 320-327, 2001.
31. Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M. G., Truss, M., Beato, M., Sica, V., Bresciani, F., and Weisz, A. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene, 12: 2315-2324, 1996.
32. Lewis, J. S., Thomas, T. J., Klinge, C. M., Gallo, M. A., and Thomas, T. Regulation of cell cycle and cyclins by 16β-hydroxyestrone in MCF-7 breast cancer cells. J. Mol. Endocrinol., 27: 293-307, 2001.
33. Leygue, E., Gol-Winkler, R., Gompel, A., Louis-Sylvestre, C., Soquet, L., Staub, S., Kuttenn, F., and Mauvais-Jarvis, P. Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture. J. Steroid Biochem. Mol. Biol., 52: 299-305, 1995.
34. Johnson, D. G., and Walker, C. L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol., 39: 295-312, 1999.
35. Gartel, A. L., and Shchors, K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp. Cell Res., 283: 17-21, 2003.
36. Carroll, J. S., Swarbrick, A., Musgrove, E. A., and Sutherland, R. L. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. Cancer Res., 62: 3126-3131, 2002.
37. Weihua, Z., Andersson, S., Cheng, G., Simpson, E. R., Warner, M., and Gustafsson, J. A. Update on estrogen signaling. FEBS Lett., 546: 17-24, 2003.
38. Shim, G. J., Wang, L., Andersson, S., Nagy, N., Kis, L. L., Zhang, Q., Makela, S., Warner, M., and Gustafsson, J. A. Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. USA, 100: 6694-6699, 2003.
39. Cowley, S. M., Hoare, S., Mosselman, S., and Parker, M. G. Estrogen receptors α and β form heterodimers on DNA. J. Biol. Chem., 272: 19858-19862, 1997.
40. Pettersson, K., Grandien, K., Kuiper, G. G., and Gustafsson, J. A. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol. Endocrinol., 11: 1486-1496, 1997.
41. Hall, J. M., and McDonnell, D. P. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology, 140: 5566-5578, 1999.
42. Pettersson, K., Delaunay, F., and Gustafsson, J. A. Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene, 19: 4970-4978, 2000.
43. Liu, M. M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Jr., Pestell, R. G., and Kushner, P. J. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J. Biol. Chem., 277: 24353-24360, 2002.
44. Lazennec, G., Bresson, D., Lucas, A., Chauveau, C., and Vignon, F. ER β inhibits proliferation and invasion of breast cancer cells. Endocrinology, 142: 4120-4130, 2001.
45. Ciana, P., Raviscioni, M., Mussi, P., Vegeto, E., Que, I., Parker, M. G., Lowik, C., and Maggi, A. In vivo imaging of transcriptionally active estrogen receptors. Nat. Med., 9: 82-86, 2003.
46. Jacobsen, B. M., Richer, J. K., Schittone, S. A., and Horwitz, K. B. New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J. Biol. Chem., 277: 27793-27800, 2002.
47. Messina, M. J., and Loprinzi, C. L. Soy for breast cancer survivors: a critical review of the literature. J. Nutr., 131: 3095S-3108S, 2001.
48. Adlercreutz, H. Phytoestrogens and breast cancer. J. Steroid Biochem. Mol. Biol., 83: 113-118, 2002.
49. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology, 138: 863-870, 1997.
50. Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J., and Nilsson, S. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol. Pharmacol., 54: 105-112, 1998.
51. Cummings, S., Eckert, S., Krueger, K., Grady, D., Powles, T., Cauley, J., Norton, L., T. N., Bjamason, N., Morrow, M., ME, L., Black, D., Glusman, J., Costa, A., and Jordan, V. The effect of raloxifene on risk of breast cancer in postmenopausal women. J. Am. Med. Assoc., 281: 2189-2197, 1999.
52. Fisher, B., Costantino, J., Wickerham, D., Redmond, C., Kavanah, M., Cronin, W., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., and Wohnark, N. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J. Natl. Cancer Inst., 90: 1371-1388, 1998.
53. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103: 843-852, 2000.
54. Shang, Y., and Brown, M. Molecular determinants for the tissue specificity of SERMs. Science (Wash. DC), 295: 2465-2468, 2002.